Key result
Pyridostigmine bromide improved neuromuscular junction transmission and reduced reported fatigue in about 70% of patients with post-polio syndrome.
Why the study?
Does pyridostigmine improve neuromuscular junction transmission and fatigue in patients with post-polio syndrome?
Does pyridostigmine improve neuromuscular junction transmission and fatigue in patients with post-polio syndrome?
Pyridostigmine may improve neuromuscular transmission and reduce fatigue in patients with post-polio syndrome.
Answers are grounded in this paper and cite their sources.
May support short-term pyridostigmine for post-polio fatigue; leaves open confirmation in randomized trials.
Electrophysiological data suggest that impairment of neuromuscular junctions transmission (NMT) may be in part responsible for the fatigability affecting the majority of patients suffering with post‐poliomyelitic syndrome (PPS). The effect of the anticholinesterase medication pyridostigmine in PPS patients was evaluated by means of voluntary activation single fibre electromyography (VA‐SFEMG), a technique that is very sensitive in revealing neuromuscular transmission disturbances. Fourteen patients fulfilling the clinical criteria for PPS were included in the study. Muscle strength assessment and VA‐SFEMG were performed in basal conditions and 1 week after oral administration of pyridostigmine bromide (MESTINON) 60 mg tablet every 8 h. The treatment induced a statistically significant improvement of neuromuscular junction transmission in most PPS patients, including patients with only musculoskeletal symptoms and with post‐poliomyelitis progressive muscular atrophy. Pyridostigmine medication also produced an improvement of reported fatigue in about 70% of fatigued patients.
No takes yet. Share an insight, caveat, or question.
Girlanda et al. (1996) studied Post-polio syndrome (PPS) (n=14). Pyridostigmine bromide vs. Basal conditions (pre-treatment) was evaluated on Neuromuscular junction transmission and reported fatigue. Pyridostigmine bromide improved neuromuscular junction transmission and reduced reported fatigue in about 70% of patients with post-polio syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: